Xcell Therapeutics (XKRX:373110) Days Payable : 10.17 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Days Payable?

Xcell Therapeutics's average Accounts Payable for the three months ended in Dec. 2024 was ₩120 Mil. Xcell Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2024 was ₩1,074 Mil. Hence, Xcell Therapeutics's Days Payable for the three months ended in Dec. 2024 was 10.17.

The historical rank and industry rank for Xcell Therapeutics's Days Payable or its related term are showing as below:

XKRX:373110' s Days Payable Range Over the Past 10 Years
Min: 13.7 Med: 20.95 Max: 113.06
Current: 32.92

During the past 6 years, Xcell Therapeutics's highest Days Payable was 113.06. The lowest was 13.70. And the median was 20.95.

XKRX:373110's Days Payable is ranked worse than
79.89% of 706 companies
in the Biotechnology industry
Industry Median: 116.445 vs XKRX:373110: 32.92

Xcell Therapeutics's Days Payable declined from Dec. 2023 (12.08) to Dec. 2024 (10.17). It may suggest that Xcell Therapeutics accelerated paying its suppliers.

Xcell Therapeutics Days Payable Historical Data

The historical data trend for Xcell Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Days Payable Chart

Xcell Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

113.06

55.60

20.95

13.70

14.23

Xcell Therapeutics Quarterly Data
	Dec19	Dec20	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial							12.08	54.78	64.36	32.38	10.17

Competitive Comparison of Xcell Therapeutics's Days Payable

For the Biotechnology subindustry, Xcell Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xcell Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xcell Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Xcell Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Xcell Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Xcell Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (133.663	+	125.575)	/	2 )	/	3325.884	*	365
=	129.619					/	3325.884	*	365
=	14.23

Xcell Therapeutics's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (113.837	+	125.575)	/	2 )	/	1073.788	*	365 / 4
=	119.706					/	1073.788	*	365 / 4
=	10.17

Xcell Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Xcell Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcell Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188

Website

http://www.xcell.media

Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines